Literature DB >> 15577943

Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway.

Ole-Morten Seternes1, Theresa Mikalsen, Bjarne Johansen, Espen Michaelsen, Chris G Armstrong, Nick A Morrice, Benjamin Turgeon, Sylvain Meloche, Ugo Moens, Stephen M Keyse.   

Abstract

Extracellular signal-regulated kinase 3 (ERK3) is an atypical mitogen-activated protein kinase (MAPK), which is regulated by protein stability. However, its function is unknown and no physiological substrates for ERK3 have yet been identified. Here we demonstrate a specific interaction between ERK3 and MAPK-activated protein kinase-5 (MK5). Binding results in nuclear exclusion of both ERK3 and MK5 and is accompanied by ERK3-dependent phosphorylation and activation of MK5 in vitro and in vivo. Endogenous MK5 activity is significantly reduced by siRNA-mediated knockdown of ERK3 and also in fibroblasts derived from ERK3-/- mice. Furthermore, increased levels of ERK3 protein detected during nerve growth factor-induced differentiation of PC12 cells are accompanied by an increase in MK5 activity. Conversely, MK5 depletion causes a dramatic reduction in endogenous ERK3 levels. Our data identify the first physiological protein substrate for ERK3 and suggest a functional link between these kinases in which MK5 is a downstream target of ERK3, while MK5 acts as a chaperone for ERK3. Our findings provide valuable tools to further dissect the regulation and biological roles of both ERK3 and MK5.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15577943      PMCID: PMC535098          DOI: 10.1038/sj.emboj.7600489

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  27 in total

1.  Cloning and characterization of mouse extracellular-signal-regulated protein kinase 3 as a unique gene product of 100 kDa.

Authors:  B Turgeon; M K Saba-El-Leil; S Meloche
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

Review 2.  Organization and regulation of mitogen-activated protein kinase signaling pathways.

Authors:  T P Garrington; G L Johnson
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

3.  Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA.

Authors:  B Wolff; J J Sanglier; Y Wang
Journal:  Chem Biol       Date:  1997-02

4.  MAPKAPK5, a novel mitogen-activated protein kinase (MAPK)-activated protein kinase, is a substrate of the extracellular-regulated kinase (ERK) and p38 kinase.

Authors:  H Ni; X S Wang; K Diener; Z Yao
Journal:  Biochem Biophys Res Commun       Date:  1998-02-13       Impact factor: 3.575

5.  Primary structure, expression and chromosomal locus of a human homolog of rat ERK3.

Authors:  S Meloche; B G Beatty; J Pellerin
Journal:  Oncogene       Date:  1996-10-03       Impact factor: 9.867

6.  ERK3 is a constitutively nuclear protein kinase.

Authors:  M Cheng; T G Boulton; M H Cobb
Journal:  J Biol Chem       Date:  1996-04-12       Impact factor: 5.157

7.  MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis.

Authors:  A Kotlyarov; A Neininger; C Schubert; R Eckert; C Birchmeier; H D Volk; M Gaestel
Journal:  Nat Cell Biol       Date:  1999-06       Impact factor: 28.824

8.  Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells.

Authors:  T Morooka; E Nishida
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

9.  PRAK, a novel protein kinase regulated by the p38 MAP kinase.

Authors:  L New; Y Jiang; M Zhao; K Liu; W Zhu; L J Flood; Y Kato; G C Parry; J Han
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

10.  Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1.

Authors:  N Kudo; B Wolff; T Sekimoto; E P Schreiner; Y Yoneda; M Yanagida; S Horinouchi; M Yoshida
Journal:  Exp Cell Res       Date:  1998-08-01       Impact factor: 3.905

View more
  59 in total

1.  The diterpenoid alkaloid noroxoaconitine is a Mapkap kinase 5 (MK5/PRAK) inhibitor.

Authors:  Sergiy Kostenko; Mahmud Tareq Hassan Khan; Ingebrigt Sylte; Ugo Moens
Journal:  Cell Mol Life Sci       Date:  2010-07-17       Impact factor: 9.261

2.  Septin 8 is an interaction partner and in vitro substrate of MK5.

Authors:  Alexey Shiryaev; Sergiy Kostenko; Gianina Dumitriu; Ugo Moens
Journal:  World J Biol Chem       Date:  2012-05-26

3.  Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes.

Authors:  Gustavo Martínez-Noël; Jeffrey T Galligan; Mathew E Sowa; Verena Arndt; Thomas M Overton; J Wade Harper; Peter M Howley
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

4.  IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling.

Authors:  Nadine Stöhr; Marcel Köhn; Marcell Lederer; Markus Glass; Claudia Reinke; Robert H Singer; Stefan Hüttelmaier
Journal:  Genes Dev       Date:  2012-01-15       Impact factor: 11.361

Review 5.  MAP kinase pathways: the first twenty years.

Authors:  Joseph Avruch
Journal:  Biochim Biophys Acta       Date:  2006-11-15

6.  Cross-Phosphorylation and Interaction between Src/FAK and MAPKAP5/PRAK in Early Focal Adhesions Controls Cell Motility.

Authors:  Sheila Figel Dwyer; Irwin H Gelman
Journal:  J Cancer Biol Res       Date:  2014-05-14

7.  ERK3 promotes endothelial cell functions by upregulating SRC-3/SP1-mediated VEGFR2 expression.

Authors:  Wei Wang; Ka Bian; Sreeram Vallabhaneni; Bin Zhang; Ray-Chang Wu; Bert W O'Malley; Weiwen Long
Journal:  J Cell Physiol       Date:  2014-10       Impact factor: 6.384

8.  Germ Line Deletion Reveals a Nonessential Role of Atypical Mitogen-Activated Protein Kinase 6/Extracellular Signal-Regulated Kinase 3.

Authors:  A Kotlyarov; M Gaestel; N Ronkina; K Schuster-Gossler; F Hansmann; H Kunze-Schumacher; I Sandrock; T Yakovleva; J Lafera; W Baumgärtner; A Krueger; I Prinz; A Gossler
Journal:  Mol Cell Biol       Date:  2019-03-01       Impact factor: 4.272

9.  Reevaluation of the Role of Extracellular Signal-Regulated Kinase 3 in Perinatal Survival and Postnatal Growth Using New Genetically Engineered Mouse Models.

Authors:  Mathilde Soulez; Marc K Saba-El-Leil; Benjamin Turgeon; Simon Mathien; Philippe Coulombe; Sonia Klinger; Justine Rousseau; Kim Lévesque; Sylvain Meloche
Journal:  Mol Cell Biol       Date:  2019-03-01       Impact factor: 4.272

10.  MAPKAP kinase 3 suppresses Ifng gene expression and attenuates NK cell cytotoxicity and Th1 CD4 T-cell development upon influenza A virus infection.

Authors:  Katharina Köther; Carolin Nordhoff; Dörthe Masemann; Georg Varga; Jay H Bream; Matthias Gaestel; Viktor Wixler; Stephan Ludwig
Journal:  FASEB J       Date:  2014-06-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.